Back
Citius Pharmaceuticals Stock Price Chart
Sell
28
CTXR
Citius Pharmaceuticals
Last Price:
0.65
Seasonality Move:
-21.45%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTXR is experiencing slight selling pressure.
Citius Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.67 | Sell |
| 20-day SMA: | 0.7 | Sell |
| 50-day SMA: | 0.77 | Sell |
| 200-day SMA: | 0.77 | Sell |
| 8-day EMA: | 0.67 | Sell |
| 20-day EMA: | 0.7 | Sell |
| 50-day EMA: | 0.74 | Sell |
| 200-day EMA: | 0.82 | Sell |
Citius Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 40.41 | Sell |
| Chaikin Money Flow: | -461439 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.66 - 0.76) | Sell |
| Bollinger Bands (100): | (0.67 - 0.83) | Sell |
Citius Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Citius Pharmaceuticals Stock
Is Citius Pharmaceuticals Stock a Buy?
- Citius Pharmaceuticals share price is 0.65 while CTXR 8-day simple moving average is 0.67, which is a Sell signal.
- The stock price of CTXR is 0.65 while Citius Pharmaceuticals 20-day SMA is 0.70, which makes it a Sell.
- Citius Pharmaceuticals 50-day simple moving average is 0.77 while CTXR share price is 0.65, making it a Sell technically.
- CTXR stock price is 0.65 and Citius Pharmaceuticals 200-day simple moving average is 0.77, creating a Sell signal.
CTXR Technical Analysis vs Fundamental Analysis
Sell
28
Citius Pharmaceuticals (CTXR)
is a Sell
Is Citius Pharmaceuticals a Buy or a Sell?
-
Citius Pharmaceuticals stock is rated a Sell
The current Citius Pharmaceuticals [CTXR] share price is $0.65. The Score for CTXR is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
Citius Pharmaceuticals Stock Info
Market Cap:
117.15M
Price in USD:
0.65
Share Volume:
895.08K
Citius Pharmaceuticals 52-Week Range
52-Week High:
1.40
52-Week Low:
0.60
Sell
28
Citius Pharmaceuticals (CTXR)
is a Sell
Citius Pharmaceuticals Share Price Forecast
-
What is the Citius Pharmaceuticals stock price today?
The Citius Pharmaceuticals stock price is 0.65 USD today. -
Will CTXR stock go up or go down?
Citius Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Citius Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Citius Pharmaceuticals is overvalued.
Is Citius Pharmaceuticals Stock a Buy?
- Citius Pharmaceuticals share price is 0.65 while CTXR 8-day exponential moving average is 0.67, which is a Sell signal.
- The stock price of CTXR is 0.65 while Citius Pharmaceuticals 20-day EMA is 0.70, which makes it a Sell.
- Citius Pharmaceuticals 50-day exponential moving average is 0.74 while CTXR share price is 0.65, making it a Sell technically.
- CTXR stock price is 0.65 and Citius Pharmaceuticals 200-day simple moving average is 0.82, creating a Sell signal.
Fundamental Analysis of Citius Pharmaceuticals
Is Citius Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.30 per share.
Technical Analysis of Citius Pharmaceuticals
Should I short Citius Pharmaceuticals stock?
- CTXR Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting Citius Pharmaceuticals is a Sell
- Citius Pharmaceuticals Relative Strength Index (RSI) is 40.41, which suggest Citius Pharmaceuticals is oversold
- The Bollinger Bands (25) for Citius Pharmaceuticals is (0.66 - 0.76), which suggest Citius Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Citius Pharmaceuticals is (0.67 - 0.83), which suggest Citius Pharmaceuticals is a Sell
* Citius Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.